Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Illumina stock

Learn how to easily invest in Illumina stock.

Illumina (ILMN) is a leading diagnostics & research business based in the US. It opened the day at $214.28 after a previous close of $211.04. During the day the price has varied from a low of $210.27 to a high of $215.19. The latest price was $212.78 (25 minute delay). Illumina is listed on the NASDAQ and employs 9,800 staff. All prices are listed in US Dollars.

How to buy Illumina stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ILMN. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Illumina stock price (NASDAQ: ILMN)

Use our graph to track the performance of ILMN stocks over time.

Illumina shares at a glance

Information last updated 2023-01-26.
Open$214.28
High$215.19
Low$210.27
Close$212.78
Previous close$211.04
Change $1.74
Change % 0.8245%
Volume 671,672
Information last updated 2023-01-25.
52-week range$173.45 - $371.16
50-day moving average $209.76
200-day moving average $222.28
Wall St. target price$243.17
PE ratio 48.4572
Dividend yield $0 (0%)
Earnings per share (TTM) $4.44

Buy Illumina stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Illumina stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Illumina price performance over time

Historical closes compared with the close of $212.78 from 2023-01-25

1 week (2023-01-17) 3.07%
1 month (2022-12-23) 11.26%
3 months (2022-10-26) -10.35%
6 months (2022-07-27) 2.71%
1 year (2022-01-27) -34.40%
2 years (2021-01-27) -50.75%
3 years (2020-01-27) 313.92
5 years (2018-01-26) 244.83

Is Illumina stock undervalued or overvalued?

Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Illumina's P/E ratio

Illumina's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, Illumina shares trade at around 48x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Illumina's PEG ratio

Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1783. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Illumina's EBITDA

Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $570 million.

The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.

Illumina financials

Revenue TTM $4.7 billion
Operating margin TTM 4.11%
Gross profit TTM $3.2 billion
Return on assets TTM 0.92%
Return on equity TTM -47.95%
Profit margin -88.36%
Book value $42.87
Market capitalisation $33.8 billion

TTM: trailing 12 months

Illumina's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Illumina.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Illumina's total ESG risk score

Total ESG risk: 9.18

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Illumina's overall score of 9.18 (as at 12/31/2018) is excellent – landing it in it in the 2nd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Illumina is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Illumina's environmental score

Environmental score: 2.22/100

Illumina's environmental score of 2.22 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Illumina's social score

Social score: 2.6/100

Illumina's social score of 2.6 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Illumina is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Illumina's governance score

Governance score: 5.36/100

Illumina's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Illumina is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Illumina's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Illumina scored a 1 out of 5 for controversy – the highest score possible, reflecting that Illumina has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Illumina Inc was last rated for ESG on: 2019-01-01.

Total ESG score 9.18
Total ESG percentile 2.42
Environmental score 2.22
Environmental score percentile 2
Social score 2.6
Social score percentile 2
Governance score 5.36
Governance score percentile 2
Level of controversy 1

Illumina share dividends

We're not expecting Illumina to pay a dividend over the next 12 months.

Have Illumina's shares ever split?

Illumina's shares were split on a 2:1 basis on 22 September 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Illumina shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Illumina shares which in turn could have impacted Illumina's share price.

Illumina share price volatility

Over the last 12 months, Illumina's shares have ranged in value from as little as $173.45 up to $371.16. A popular way to gauge a stock's volatility is its "beta".

ILMN.US volatility(beta: 1.13)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 1.1318. This would suggest that Illumina's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Illumina overview

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Frequently asked questions

What percentage of Illumina is owned by insiders or institutions?
Currently 0.347% of Illumina shares are held by insiders and 93.025% by institutions.
How many people work for Illumina?
Latest data suggests 9,800 work at Illumina.
When does the fiscal year end for Illumina?
Illumina's fiscal year ends in December.
Where is Illumina based?
Illumina's address is: 5200 Illumina Way, San Diego, CA, United States, 92122
What is Illumina's ISIN number?
Illumina's international securities identification number is: US4523271090
What is Illumina's CUSIP number?
Illumina's Committee on Uniform Securities Identification Procedures number is: 452327109

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site